KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Unitedhealth (UNH) Cash & Equivalents (2016 - 2025)

Unitedhealth (UNH) has disclosed Cash & Equivalents for 17 consecutive years, with $24.4 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 3.74% to $24.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.4 billion through Dec 2025, down 3.74% year-over-year, with the annual reading at $24.4 billion for FY2025, 3.74% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $24.4 billion at Unitedhealth, down from $27.2 billion in the prior quarter.
  • The five-year high for Cash & Equivalents was $41.9 billion in Q1 2023, with the low at $266.0 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $24.9 billion, with a median of $25.9 billion recorded in 2022.
  • The sharpest move saw Cash & Equivalents tumbled 87.72% in 2022, then skyrocketed 3161.86% in 2024.
  • Over 5 years, Cash & Equivalents stood at $2.2 billion in 2021, then crashed by 87.72% to $266.0 million in 2022, then surged by 191.73% to $776.0 million in 2023, then soared by 3161.86% to $25.3 billion in 2024, then decreased by 3.74% to $24.4 billion in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $24.4 billion, $27.2 billion, and $28.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.